catalog number :
MBS576635
products type :
Inhibitor
products full name :
AZD9291
products short name :
[AZD9291]
products gene name :
[AZD9291]
storage stability :
2 years -80°C in solvent. 3 years -20°C in powder
app notes :
Cell Assay: AZD-9291 is dissolved in DMSO and stored, and then diluted with appropriate medium before use[1]. PC-9 cells are seeded into T75 flasks (5×105 cells/flask) in RPMI growth media and incubated at 37°C, 5% CO2. The following day the media is replaced with media supplemented with a concentration of EGFR inhibitor equal to the EC50 concentration predetermined in PC-9 cells. Media changes are carried out every 2-3 days and resistant clones allowed to grow to 80% confluency prior to the cells being trypsinised and reseeded at the original seeding density in media containing twice the concentration of EGFR inhibitor. Dose escalations are continued until a final concentration of 1.5 uM Gefitinib, 1.5 uM Afatinib, 1.5 uM WZ4002 or 160 nM AZD-9291 are achieved[1]. Reference:. 1. Patent. 2013, WO2013014448 A1. 2. Cross, et al. Mol Cancer Ther. 2013, 12, A109.
other info1 :
CAS Number: 1421373-65-0. Molecular Formula: C28H33N7O2. Solubility: DMSO: 92 mg/mL (184.1 mM). Ethanol: 22 mg/mL (44 mM). Water: < 1 mg/mL. Receptor (IC50): EGFR (Exon 19 deletion): 12.92nM. EGFR (L858R/T790M): 1nM. Animal Experiment: Animal Model: Mice
products description :
Osimertinib is a small molecule tyrosine kinase receptor inhibitor and antineoplastic agent that is used in the therapy of selected forms of advanced non-small cell lung cancer (NSCLC).
size2 :
1ml/10mM (in DMSO)